Ever Source Wealth Advisors, LLC Crispr Therapeutics Ag Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 84,880 shares of CRSP stock, worth $3.08 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
84,880
Previous 172
49248.84%
Holding current value
$3.08 Million
Previous $6,000
48033.33%
% of portfolio
0.17%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$369 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$220 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$138 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$101 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$92.2 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.83B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....